MedTrace Logo

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

NCT05476172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-07-21

No results posted yet for this study

Summary

This randomized controlled study aims to investigate the efficiency of medical treatment modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and twelve months after treatment.

Conditions

  • Endometriosis

Interventions

DRUG

Dienogest Pill

The effect of dienogest on endometriosis pain symptoms.

DRUG

Norethindrone Acetate

The effect of Norethindrone Acetateon endometriosis pain symptoms.

Sponsors & Collaborators

  • Uludag University

    lead OTHER

Principal Investigators

  • Kiper Aslan, Assoc. Prof. · Uludag University

  • Isil Kasapoglu, Assoc. Prof. · Uludag University

  • Gurkan Uncu, Prof. · Uludag University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-05-30
Completion
2023-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476172 on ClinicalTrials.gov